International group of multidisciplinary experts from China, Italy, Estonia and Finland, has written a comprehensive and critical review on advantages...

Biohit’s management team member Business Development Director Lea Paloheimo will retire as planned 31st of January 2019. Lea Paloheimo has...

Nicotine dependence is an increasing health problem even if smoking itself shows a declining trend. Nicotine-containing products frequently remain “on”...

Biohit ColonView test is a new-generation fecal immunochemical test (FIT) designed for detection of fecal occult blood (FOB) in subjects...

Biohit’s management team member Chief Medical Director Kari Syrjänen will retire as planned 31st of December 2018. Kari Syrjänen has been...

Biohit Oyj will release its financial statements for 2018 ... Read more

International Healthy Stomach Initiative (HSI) organized on Tuesday, October 2, 2018 in several countries all over the world public events...

A total number of 52,709 new Biohit Oyj B-shares have been subscribed for with stock options I 2013 between 5...